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COMPETING HIV STRAINS
AND IMMUNE SYSTEM RESPONSE
THIERRY GOBRON1, MARIO SANTORO2, AND LIVIO TRIOLO2
Abstract. We consider a simple deterministic model which describes an asymmetric
competition between an immune system with a specific and powerful response, and a
virus with a broad toxicity and fast mutations. Interest in this model relies on the fact
that in spite of it simplicity, it reproduces some of the features of the asymptomatic phase
of the infection by HIV-1. In particular, there is a domain of parameters in which the
dynamics is characterized by the apparition of “blips”, associated here to an instability
which develops at high virus reproduction rate. Various possible extensions of this simple
model are discussed, in particular in view of its applications in the context of HAART
therapy.
1. Introduction
The Human Immunodeficiency Virus (HIV) infects humans in a peculiar way: it attacks
and develops precisely on the cells which are the keystone of the immune defense system.
A number of theoretical papers have studied the subtle mechanisms which may describe
this evolution and much work in modeling has been produced since the first attempts by
Nowak-May [1], Perelson-Nelson [2] and Nowak-Bangham [3]. In spite of true successes,
mathematical modeling of such biological systems remains a challenge, not because of
lack of good theoretical approaches, but on the contrary because of intrinsic difficulties
to distinguish experimentally between them. In this work, we try to escape this kind of
dilemma in the following way: we elaborate on previously considered deterministic models,
but we consider it from the point of view of strategy, retaining only the following facts from
the original problem: the immune system has a powerful specific response while the virus
is in some sense weaker, but faster to adapt. In other words, we construct a “predator–
predator” model (rather than a “predator-prey”), where the asymmetry comes from the
very different strategy between both. This results in a model with few parameters, but
a surprisingly rich and suggestive dynamics. Values of parameters, or at least orders of
magnitude, are estimated from clinical data, in order to get some experimental feedback.
Such a scheme seems to us to be new: one one hand, only predator-prey models (in a sense
or another) have been considered so far, and in the other hand, models considering viral
mutation don’t include it as a part of a deterministic process, but through an external or
stochastic mechanism (see for instance [6]).
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One of the main results of the present approach is the appearance of an instability in
a sensible range of parameters, which is strongly reminding of the so-called “blips”. If
it were so, these “blips” could be interpreted as interesting probes of the viral dynamics,
rather than uncorrelated, random events.
A number of important features are of course lacking in this model. Some of them
(naive cell production, virus fitness landscape, specific behavior under HAART therapy,
· · · ) could be rather easily inserted in this frame [4], [5]. However we believe that the
simplicity and robustness of this model is its main strength, and that it can be turned out
in an accurate tool without much efforts.
In section 2, we describe the model, give some hints on its construction and the connec-
tion of parameters with clinical data. In section 3, we explore its dynamics, and in last
section 4, we discuss some of the features and anticipate on further developments.
2. Model: scope, construction and parameters.
In this section , we describe a system of differential equations in which we try to insert
as much as possible of the main features of the HIV-1 infection. Departing from previous
modeling based on a predator-prey model in various forms [1],[6], we consider the infective
virus and the immune system as two predators which have developed different strategies to
win over the other: the former has a relatively slow dynamics but a strong specific activity
while the latter has a fast dynamics, a smaller but largely aspecific toxicity and a high
mutation rate.
First, we define a simple genomic space as a set of indices S = {1, · · · , N} where N is
very large and represents the number of possible virus mutants as seen from the immune
system. Hereafter we will make very simple assumptions about this space, but both a more
realistic topology of the genomic space and a fitness landscape could enter here. The viral
system is then described as a collection of variables {Vσ(t)}σ∈S, giving the density of each
virus strain at time t. The immune system is described as a collection of densities of cells
{Xσ(t)}σ∈S, each specific to a given strain. The connection with clinical data is made by
identifying the {Xσ} to the densities of CD4
+ T-helper cells. This choice reflects the fact
that this is the limiting factor from the kinetic point of view, effective destruction of viruses
taking place in a short time after their binding to a CD4+ cell. In the same spirit, we do
not describe directly a population of infected cells, assuming that the virus dynamics is
fast enough so that both population densities stay strongly coupled at all times. Finally
we also assume that the mean densities are the only variable which matters, irrespective
of the repartition in the body and the possible interaction with other agents.
The evolution of these two sets of population densities starting from given initial condi-
tions is defined by the following differential equations for all σ ∈ S:
dXσ
dt
=
Λ0
N
(
1 +
DVσ
1 + V T
)
−Xσ
(
1 + V T + AVσ
)
(2.1)
dVσ
dt
= ωVσ
(
XT − BXσ − C
)
+ ε (∆V )σ (2.2)
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where XT and V T are the total population densities for the immune system and the viruses:
XT =
∑
σ∈S
Xσ V
T =
∑
σ∈S
Vσ
One of the important simplification we have made here is to avoid the description of a
population of naive cells, specializing after (direct or indirect) contact with a particular
virus strain. Instead, we distribute initially the (naive) CD4+ cells uniformly over (a
segment of ) the genomic space. This is certainly not the true behavior of the immune
system, but has to be considered as a (good) mathematical trick. We will discuss at the
end some of the consequences of this assumption at the mathematical level and what one
can expect after removing it. Here Λ0 is the density of (naive) CD4
+ cells in the absence
of infection.
For V T = 0, they are arbitrarily distributed over the whole genomic space to avoid the
description of an activation process. In the presence of a given strain of viruses, the density
of corresponding T-cells increases linearly for low viral load, and is bounded. Here again
the choice of this particular dependency on the virus density is dictated by simplicity. It is
however important that it stays bounded at large virus load. Death rate is made of three
parts: a natural death rate, an aspecific viral death rate proportional to the total virus
density, and a specific viral death rate emphasizing an higher probability for a T-cell to be
infected by the viral strain it recognizes.
Viruses replicate through cell infection, so both virus replication and death rates are
proportional to strain density. Thus the right-hand side of equation (2.2) contains three
terms proportional to Vσ: an aspecific replication rate; a term representing the balance
between specific replication rate and specific death rate, the former being larger, thus with
an overall negative sign; an aspecific death rate. The last term in (2.2) describes the virus
mutations. It is taken as a discrete laplacian derived from the metrics ascribed to the
genomic space. Various choices for this metrics are possible. In the following, we will
always assume that all strains have the same fitness, so that the metrics depend on the
connectivity only.
In spite of its simplicity, this model is thought to be able to capture some of the features
of the specific immune response to HIV infection. The metrics being given, the model
described above depends on 6 parameters: A, B, C, D, ω and ε. Three additional scaling
parameters fix the density and time units.
In order to get an expression for them in terms of clinical data, we first re-write the
evolution equations for the “true” quantities: X˜σ, densities of CD4
+ cells, X˜∗σ,τ , densities
of cells of type σ infected by a virus of type τ , V˜ ∗σ , densities of viruses and t˜, time in days.
We write
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dX˜σ
dt˜
=
λ0
N
(
1 +
dV˜σ
dX + kV˜ T
)
− X˜σ
(
dX + kV˜
T + k′V˜σ
)
dX˜∗σ,τ
dt˜
= X˜σ
(
kV˜τ + k
′δσ,τ V˜σ
)
− dX∗X˜
∗
σ,τ − µX˜
∗
σ,τX˜τ + ρ∆τ
(
X˜∗σ,τ
)
(2.3)
dV˜τ
dt˜
= ZdX∗
∑
σ
X˜∗σ,τ − dV V˜τ
Using data from [2],[7] and references therein, estimates for coefficients are:
λ0 = 10
4 ml−1 day−1
dX = 0.01 day
−1
k = 2.410−8 ml day−1
dX∗ = 1. day
−1
Z = 103 − 105 virions per infected cell
dV = 23 day
−1
ρ = 10−5 day−1
Other parameters are less easy to estimate. d represents the capacity of the immune
system to reinforce its specific response; k′ > 0 indicates that CD4+ cells have a larger
probability to be infected by their specific virus strain. Both are believed to be positive
and reasonably larger than k; µ should be large enough to allow for an effective specific
immune response. Assuming a fast dynamics for the viruses, we set dV˜σ
dt˜
= 0 at all time,
which induces a relationship between infected cells and virus densities:
V˜τ =
ZdX∗
dV
∑
σ
X˜∗σ,τ (2.4)
Inserting this expression in the equation for the infected cells leads to an equation for
the virus densities on a slow time scale. Under scaling t = dX t˜, Xσ =
dX
λ0
X˜σ, Vσ =
k
dX
V˜σ,
the system of equations (2.1)–(2.2) is recovered with Λ0 = 1 and the following expressions
and orders of magnitude for the other parameters:
A = k
′
k
B = µ dV
k Z dX∗
− k
′
k
≈ 106 (with µ = 1 ml day−1 and Z = 103).
C = dX dV
Z k dX∗
≈ 1 (with Z = 103).
D = d
k
ω =
k Z dX∗ λ0
dV d
2
X
≈ 102
ε = ρ
dX
≈ 10−3
The values for A and D are not known but will be taken in the following in the range
[1, 102]. Note that the scaling factors of CD4+ cells and virions are of the same order of
magnitude so that in the reduced coordinates a density of order 1 corresponds to a true
density of about 106µl−1, while the reduced time unit is of order 100 days.
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In the following section, we will explore the behavior of this model, first by considering a
reduced model with no mutations, which behavior will help then to analyze the full model.
3. Dynamics
3.1. Stationary solutions in the absence of mutations.
In the absence of mutations, it is not hard to show that the set of stationary solutions
is particularly simple: in terms of viral populations, either there is no virus, Vσ = 0 for all
σ ∈ S, or there exist K strains of virus of equal density, 1 ≤ K ≤ N . In this subsection, we
analyse the behavior of these solutions, for two reasons: first, it should give some insights
on the full system when mutation rates are small with respect to other parameters; second,
it gives a connection with previously studied models [1] where mutations are not explicitly
taken into account.
The simplest stationary solution is the configuration with no virus, V T = 0, XT = Λ0,
which exists for all values of parameters. It is locally stable for C > Λ0(1−
B
N
) and locally
unstable otherwise.
The other stationary solutions can be described as follows. Let K, 1 ≤ K ≤ N , be the
number of virus strains with positive density in a given stationary solution with viruses.
The densities of these strains are necessarily equal and the overall densities of CD4+ cells
and viruses are related by
XT =
Λ0
1 + V T
(
1 +
K
N
(D − A)V T
K + (K + A)V T
)
(3.1)
while the density of viruses V T is solution of the following equation
C =
Λ0
N
(A(N −K)−D(B −K)
A(1 + V T )
+
K(B −K)(D − A)
K + (K + A)V T
)
(3.2)
This equation has at most two real positive solutions in V T , depending on the value of the
parameters. The role of the parameters as well as a qualitative behavior of these solutions
can be drawn directly from the above two formulas:
The value of C reflects both the “bare” virus death rate and the a-specific response of
the immune system which is not described explicitly in this model. Since the right hand
side of (3.2) is bounded by Λ0, the virus density will be zero in the stationary regime if C
is high enough, irrespective of the behavior of the specific immune system.
The specific response is described by two parameters, B, the specific cytotoxicity, and D
which controls the increase of specific CD4+ cell production in presence of the corresponding
virus strain. The action of the virus is controlled by ω, the virus reaction rate scaling factor,
N the size of the system on which the virus lives, and A the killing rate of specific CD4+
cells. The values of the ratios B
N
and D
A
control the behavior of equilibrium solutions in
two different ways:
When N > B and C < Λ0(N−B)
N
, the values of C and B are too small to eradicate the
virus and there is one solution for each K ≥ 1. If D
A
> N
B
> 1 the production of specific
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Figure 1. Domain of existence of solutions in the plane (B,C) for D > A
(D = 30, A = 10). The linear stability limit of the virus free solution
C = Λ0(1−
B
N
) sets the limit of existence of solutions with V T 6= 0. Dashed
lines: boundaries of domains of existence of limit cycles for ω = 30, ω = 100,
ω = +∞ (for K = 5).
CD4+ cells is high enough to limit the density of viruses (V T is bounded in the limit
C −→ 0), provided
K <
DB − AN
(N −B) + (D − A)
(3.3)
For larger values of K or smaller values of D, the specific response has a very little effect
in the sense that V T could grow without bounds as C goes to zero.
In the other case, C > Λ0(N−B)
N
, the immune response is high enough to sweep out low
densities of viruses. However if in addition D
A
< N
B
, a sufficiently high densities of viruses
will deplete the specific CD4+ cell population and a pair of solutions with a small number
of high density virus strains may appear (for C low enough and K as in (3.3)). For D
A
> N
B
this density effect is too small and the unique solution will be virus free.
The linear stability of the stationary solutions with V T 6= 0 reveals interesting behaviors.
We first recall that whenever there are two stationary solutions for fixed K, the one with
the smallest density is necessarily unstable and have to be discarded. The first interesting
instability is the following: When D > A, any new strain of viruses with small positive
density will tend to grow out while for A > D, strains with densities slightly smaller than
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Figure 2. Domain of existence of solutions in the plane (B,C) for D < A.
This domains extends now beyond the linear stability limit of the virus free
solution C = Λ0(1−
B
N
). Here D = 15, A = 30. Dashed lines: boundaries of
domains of existence of limit cycles for ω = 30, ω = 100, ω = +∞ (for
K = 10).
the equilibrium one will die out. This effect may appear in some sense paradoxical, but
recalls a known behavior of HIV infection: if the specific toxicity B is too small to eradicate
the virus, increasing the population of CD4+ cells does not help and contributes instead to
virus growth. This instability will be also important in presence of mutations as the ratio
D
A
will control the number of strains.
The other possible linear instability is associated with the apparition of a pair of complex
eigenvalues of the linearized map, with positive real part. When the following expression
is positive,
ω−1c =
λ0V
T
N(1 + V T )(K + (K + A)V T )
×
(
K
(
(B −K)(A−D)−K(N −B)
)
2K + (2K + A)V T
+
D(B −K)V T
(1 + V T )2
)
(3.4)
then for all ω > ωc, the solution with K strains is unstable. Such an instability generally
indicates the existence of a limit cycle rather than a stable fixed point. We will further
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explore this point in the next subsection which is devoted to the dynamics in a restricted
setting.
3.2. Non linear evolution of K identical strains.
In this subsection, we analyze the evolution in the absence of virus mutations, starting
from a set of particular initial conditions in which K virus strains are present with the same
density, and T-cell densities depend only on the presence or absence of the corresponding
viral strain. By symmetry, these properties will be preserved by time evolution, and the
system will be described by three densities: Activated T-cells Xa, non-activated T-cells
Xn and virus V . Here V
T = KV and XT = KXa + (N − K)Xn. The time evolution is
given by a system of three coupled differential equations, with an explicit dependence on
the number of strains K.
dXa
dt
=
Λ0
N
(K +
DV T
1 + V T
)−Xa(1 +
K + A
K
V T )
dXn
dt
=
Λ0(N −K)
N
−Xn(1 + V
T )
dV T
dt
= ωV T (Xn −
B −K
K
Xa − C) (3.5)
The solutions (Xa(t), Xn(t), V (t)) are bounded in (R
+)3 at all times provided there are
so initially. There is at most three admissible stationary solutions which coincide to those
found in the previous subsection, and the discussion on their existence and stability is the
same as above, except for the variation in the number of strains which is here blocked by
construction. The system has either a stable stationary solution or a limit cycle (in the
(XT , V T ) plane ) and the dependence on the parameters is the same as in figures (1) for
D > A and (2) for D < A. Numerical simulations are an easy way to get informations on
the dynamics. When there exists a stable stationary solution with non zero virus density,
a typical behavior consists in an initial virus peak and a successive lower CD4+ density
as in figure (3). Note that the lowering of CD4+ density is smaller than what is expected
from clinical data. This is probably due to the mode of creation of “naive” cells in this
model which creates an excessive rigidity in the CD4+ density distribution.
When the virus creation rate is high enough, ω > ωc, the stationary solution becomes un-
stable and the system converges to a periodic solution around a limit cycle in the (XT , V T )
plane, with a period of a few time units (about one year in the original variables). As shown
in figure (4) , CD4+ has a slightly oscillating profile, while virus density has very sharp
peaks. These peaks are reminding the so-called blips which may appear in the dynamics
of HIV-1 infection. This suggests that “blips” are a consequence of a dynamical instability
in the virus dynamics rather than a random, uncorrelated, event. If this were the case,
the parameters of the blips would be necessarily related to those of the main dynamical
course.
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Figure 3. Time evolution of virus (continuous line) and CD4+ (dashed
line) densities toward a stable equilibrium point starting from an initially
low virus density. Here K = 10, B
N
= .36, C = .6, A = 56., D = 21., ω = 20..
3.3. Dynamics of mutable virus.
We now consider the full dynamics described by equations (2.1)–(2.2), including mu-
tations which we detail now. In order to keep with simple hypothesis, we give to our
“genomic space” a one dimensional topology, thinking of it as a coordinated sequence of
favored strains, rather than a full set of possible mutations, which would have to be more
complex and should come along with a notion of fitness landscape. Here we consider that
all (accessible) strains have the same parameters and can mutate to their “neighbors” at
a constant rate. Thus we write the mutation term (∆V )σ appearing in equation (2.2), as
a one dimensional discrete laplacian:
(∆V )σ = Vσ+1 + Vσ−1 − 2Vσ (3.6)
We do not explicitly consider boundary conditions as filling up the full system is meaning-
less. When D > A, the system may develop traveling wave solution. Here we consider the
opposite case A > D large enough, when competition between strains opposes to constant
mutation and possibly leads to a stationary number of strains. We first define the virus
“diversity” as the quantity K∗,
K∗ =
(
∑
σ Vσ)
2∑
σ V
2
σ
(3.7)
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Figure 4. Time evolution of virus (continuous line) and CD4+ (dashed
line) densities for larger virus creation rate. Virus density develop sharp
peaks reminiscent of so- called “blips” . Same parameters as in figure 3 with
a larger value for ω = 70.
This formula is the inverse of the Simpson index [1] and gives a measure of how many strains
are present. When all of these virus strains have exactly the same density as in previous
subsections, it is just equal to the number of strains K; for more general distributions, it
evaluates the number of strains with a noticeable density.
For values of parameters compatible with the existence of a stationary solution in absence
of mutations, one expects that for small vales of the mutation rate, the system has a
stationary solution close to the case without mutations. The time evolution now involves
the number of strains and a typical example of this behavior is shown in figure 5 where the
number of strains grows from initially one to roughly six at equilibrium. The situation is
more complicated in the domain of parameters allowing for the presence of blips: now the
number of strains oscillates with the virus density, linearly increasing between peaks, and
sharply dropping just before the peak. In this latter case, the limit cycle has typically a
triangular shape in the plane ’number of strains’-’virus density’. This is shown in figure 7
where each side is characterized by a particular transformation of the virus density profile
(G) growth of viral load, (S) Selection of strains, (T) Toppling of the selected strains
and apparition of new ones. Again, this evolution of the virus density profile is strongly
reminiscent of so-called “blips” [8] which are present in infections by HIV-1. Note that in
this model, there is no notion of fitness, but there is a selection mechanism. In this pure
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Figure 5. Time evolution towards a stable equilibrium in presence of mu-
tations. The dotted line represents the virus diversity (see text) and stabilize
around 6. B
N
= .36, C = .6, A = 56., D = 21., ω = 10., ǫ = .5.
deterministic model, the index of selected strains depend of course on the initial conditions
but any small random perturbation would blur this point.
4. Conclusion and outlook.
In this work, we have devised a simple deterministic model, trying to catch some of the
main issues of HIV-1 infection from the point of view of strategy, rather than describing
as much as possible of this complex process. This model can be viewed as a “predator-
predator” model in the sense that the birth rates of both increase with the density of the
other, and the richness of the dynamics comes from the asymmetry in the behavior of both
parts: the virus has fast replication and mutation rates and a broad toxicity while the
immune system has a stronger but slowly reacting specific response.
High virus mutability is a key feature dictating most of the structure of the model,
while the strength of the specific immune response allows to use a very simple notion of
“genomic space” in which mutations can be imbedded, and keep only a very small number
of parameters, most of which being related to clinical data. Various kind of time evolutions
are found, in which dynamical relations between virus density and virus diversity may show
up. In particular, peaks of virus density appear in some cases as a consequence of a too high
virus replication rate. Such phenomena is strongly reminding of the clinically observed blips
and it is thus tempting to suggest that blips are the consequence of a dynamical instability
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Figure 6. Time evolution towards a limit cycle in presence of mutations.
The dotted line represents the virus density (see text) which oscillates be-
tween 2 and 5. B
N
= .36, C = .6, A = 56., D = 21., ω = 54., ǫ = .3.
and not random or unrelated events. Correlations in the clinical data may possibly be
found in support to this hypothesis.
A number of important issues have been left aside in this model. The simplest gen-
eralization is the introduction of a compartmentalization to mimic the decrease of viral
load under efficient HAART therapy. However, the main interest here would be to model
virus rebound under therapy and this requires deeper modifications. By construction, our
specific immune system can cover efficiently only a small genomic space, and only its in-
terpretation as a sequence of favored viral strains is meaningful. A first step would be
an enlargement of this space, the introduction of a less naive topology and a fitness land-
scape, with possible changes induced by therapy. In turn, maintaining an efficient specific
immune response on such a large space requires its confinement essentially where virus is
present. And a good way to implement it is the introduction of a population of naive cells
and specialization mechanisms. Such a more refined model is in our view the next step to
aim for.
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